Weihai Baihe Biology Technological Co. Ltd.
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutrit… Read more
Weihai Baihe Biology Technological Co. Ltd. (603102) - Total Liabilities
Latest total liabilities as of June 2025: CN¥196.93 Million CNY
Based on the latest financial reports, Weihai Baihe Biology Technological Co. Ltd. (603102) has total liabilities worth CN¥196.93 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Weihai Baihe Biology Technological Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Weihai Baihe Biology Technological Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Weihai Baihe Biology Technological Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Weihai Baihe Biology Technological Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
ARTRYA Ltd
AU:AYA
|
Australia | AU$2.39 Million |
|
VIVO Cannabis Inc
PINK:ABCCF
|
USA | $15.93 Million |
|
Albatron Technology Co Ltd
TWO:5386
|
Taiwan | NT$701.16 Million |
|
Shenyang Cuihua Gold and Silver Jewelry Co Ltd
SHE:002731
|
China | CN¥4.31 Billion |
|
Hefei Changqing Machinery Co Ltd
SHG:603768
|
China | CN¥3.91 Billion |
|
GTL Infrastructure Limited
NSE:GTLINFRA
|
India | ₹102.83 Billion |
|
Limes Schlosskliniken AG
XETRA:LIK
|
Germany | €20.16 Million |
|
Comintel Corporation Berhad
KLSE:7195
|
Malaysia | RM807.08 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Weihai Baihe Biology Technological Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.97 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Weihai Baihe Biology Technological Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Weihai Baihe Biology Technological Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Weihai Baihe Biology Technological Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥209.81 Million | -5.36% |
| 2023-12-31 | CN¥221.70 Million | -7.60% |
| 2022-12-31 | CN¥239.93 Million | +18.66% |
| 2021-12-31 | CN¥202.20 Million | +33.96% |
| 2020-12-31 | CN¥150.94 Million | -4.02% |
| 2019-12-31 | CN¥157.26 Million | -- |